27.10.2014
- GlaxoSmithKline (GSK), the UK's largest pharmaceutical producer, said development of the company's experimental Ebola vaccine candidate is progressing "at an unprecedented rate,"...
29.08.2014
- An experimental Ebola vaccine from GlaxoSmithKline is being fast-tracked into clinical trials with human patients, and the company plans to immediately begin building a stockpile...
29.05.2013
- GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring Swiss-based Okairos for €250 million ($321 million) - the latest bolt-on biotech buy...
